Standard BioTools
LAB
LAB
145 hedge funds and large institutions have $391M invested in Standard BioTools in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.66% less ownership
Funds ownership: 92.76% → 88.1% (-4.7%)
17% less capital invested
Capital invested by funds: $472M → $391M (-$80.9M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
145
Holding in Top 10
3
Calls
$5.23M
Puts
$2.6M
Top Buyers
| 1 | +$9.4M | |
| 2 | +$3.51M | |
| 3 | +$3.4M | |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$3.25M |
| 5 |
Two Sigma Investments
New York
|
+$3.15M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$9.68M | |
| 3 | -$8.78M | |
| 4 |
Millennium Management
New York
|
-$8.45M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$6.04M |